{"id":"W3095171343","doi":"10.1016/s0959-8049(20)31128-x","title":"Theranostic 64Cu-DOTHA2-PSMA for metastatic prostate cancer treatment, a preclinical study","year":2020,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Radioligand; Biodistribution; Prostate cancer; Glutamate carboxypeptidase II; Medicine; In vivo; Cancer research; Radionuclide therapy; Oncology; Pharmacology; Nuclear medicine; Cancer; Internal medicine; Biology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000277636,0.0001461246,0.0003740794,0.00001884375,0.00005716315,0.0000218942,0.0001222035,0.000009719292,0.0002970921],"category_scores_gemma":[0.0001758466,0.00009825778,0.0001858127,0.0001274259,0.00005369269,0.00005087246,0.00001234178,0.0001972509,0.00001291076],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006859857,"about_ca_system_score_gemma":0.0002105457,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003642247,"about_ca_topic_score_gemma":0.00000153939,"domain_scores_codex":[0.9987953,0.0001284497,0.0005279136,0.0001829953,0.0001948673,0.0001704815],"domain_scores_gemma":[0.9988996,0.0001591935,0.0002652445,0.0001204294,0.0001949782,0.0003605672],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02387902,0.007770263,0.09924099,0.001112658,0.009312172,0.002173507,0.01869549,0.002261764,0.2176927,0.00005644644,0.02667775,0.5911272],"study_design_scores_gemma":[0.04919359,0.01418557,0.04477944,0.0005124034,0.007906992,0.000197809,0.001423297,0.001617035,0.05643736,0.00005763231,0.8230906,0.0005982407],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9675348,0.006575673,0.000641837,0.02240525,0.0001620821,0.0012525,0.00009932313,0.00002798391,0.001300516],"genre_scores_gemma":[0.9947474,0.0009140552,0.0005300772,0.001479935,0.001099039,0.0000685796,0.000002488988,0.00004096611,0.001117428],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7964129,"threshold_uncertainty_score":0.4006836,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1731371315537489,"score_gpt":0.4549716049300678,"score_spread":0.2818344733763188,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}